Thomas Kielsgaard Kristensen

2.9k total citations
52 papers, 1.1k citations indexed

About

Thomas Kielsgaard Kristensen is a scholar working on Immunology, Genetics and Rheumatology. According to data from OpenAlex, Thomas Kielsgaard Kristensen has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Genetics and 14 papers in Rheumatology. Recurrent topics in Thomas Kielsgaard Kristensen's work include Mast cells and histamine (17 papers), Urticaria and Related Conditions (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Thomas Kielsgaard Kristensen is often cited by papers focused on Mast cells and histamine (17 papers), Urticaria and Related Conditions (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Thomas Kielsgaard Kristensen collaborates with scholars based in Denmark, Germany and United States. Thomas Kielsgaard Kristensen's co-authors include Michael Møller, Hanne Vestergaard, Sigurd Broesby‐Olsen, Carsten Bindslev‐Jensen, Charlotte G. Mørtz, Steven A. Greenberg, Jack L. Pinkus, David M. Dorfman, Sarah S. Cohen and Anthony A. Amato and has published in prestigious journals such as The Lancet, Blood and Brain.

In The Last Decade

Thomas Kielsgaard Kristensen

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kielsgaard Kristensen Denmark 17 618 430 407 204 140 52 1.1k
C. Bulaï Livideanu France 17 387 0.6× 111 0.3× 299 0.7× 95 0.5× 135 1.0× 81 824
Patricia Rohane United States 9 360 0.6× 226 0.5× 221 0.5× 436 2.1× 55 0.4× 10 981
Giacomo Caldarola Italy 23 648 1.0× 56 0.1× 298 0.7× 172 0.8× 93 0.7× 93 1.2k
Bonnie Vlahos United States 23 752 1.2× 180 0.4× 1.5k 3.6× 80 0.4× 209 1.5× 62 1.8k
J. R. Kalden Germany 19 732 1.2× 75 0.2× 964 2.4× 86 0.4× 88 0.6× 57 1.7k
Kenneth R. Wilske United States 18 336 0.5× 83 0.2× 678 1.7× 57 0.3× 184 1.3× 35 1.2k
Karin C. Nabbe Netherlands 14 282 0.5× 89 0.2× 275 0.7× 35 0.2× 51 0.4× 21 795
Stephen Kelly United Kingdom 18 560 0.9× 55 0.1× 800 2.0× 52 0.3× 90 0.6× 40 1.4k
Arthur F. Kavanaugh United States 13 377 0.6× 106 0.2× 371 0.9× 51 0.3× 26 0.2× 20 689
Richárd Márkus United States 15 417 0.7× 207 0.5× 66 0.2× 267 1.3× 29 0.2× 30 1.2k

Countries citing papers authored by Thomas Kielsgaard Kristensen

Since Specialization
Citations

This map shows the geographic impact of Thomas Kielsgaard Kristensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kielsgaard Kristensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kielsgaard Kristensen more than expected).

Fields of papers citing papers by Thomas Kielsgaard Kristensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kielsgaard Kristensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kielsgaard Kristensen. The network helps show where Thomas Kielsgaard Kristensen may publish in the future.

Co-authorship network of co-authors of Thomas Kielsgaard Kristensen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kielsgaard Kristensen. A scholar is included among the top collaborators of Thomas Kielsgaard Kristensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kielsgaard Kristensen. Thomas Kielsgaard Kristensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristensen, Thomas Kielsgaard, et al.. (2025). Sexually transmitted infections (Chlamydia trachomatis, genital HSV, and HPV) and female fertility: A scoping review. Sexual & Reproductive Healthcare. 43. 101067–101067. 2 indexed citations
2.
Hussmann, Dianna, Anna Starnawska, Iben Daugaard, et al.. (2022). Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH analysis. Genomics. 114(6). 110510–110510. 1 indexed citations
3.
Horny, H.‐P., Thomas Kielsgaard Kristensen, Sigurd Broesby‐Olsen, et al.. (2022). Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis. Journal of the European Academy of Dermatology and Venereology. 36(8). 1367–1375. 12 indexed citations
4.
Hansen, Marcus Høy, Oriane Cédile, Lene Hyldahl Ebbesen, et al.. (2020). Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma. Experimental Hematology. 84. 7–18.e12. 7 indexed citations
5.
Graversen, Martin, Claus Wilki Fristrup, Thomas Kielsgaard Kristensen, et al.. (2019). Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC). Journal of Clinical Pathology. 72(5). 368–372. 16 indexed citations
6.
Broesby‐Olsen, Sigurd, Hanne Vestergaard, Charlotte G. Mørtz, et al.. (2017). Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations. Allergy. 73(1). 230–238. 69 indexed citations
7.
Greenberg, Steven A., Jack L. Pinkus, Anthony A. Amato, Thomas Kielsgaard Kristensen, & David M. Dorfman. (2016). Association of inclusion body myositis with T cell large granular lymphocytic leukaemia. Brain. 139(5). 1348–1360. 79 indexed citations
8.
Søgaard, Rikke, et al.. (2016). Observational study identifies non-attendance characteristics in two hospital outpatient clinics.. PubMed. 63(10). 16 indexed citations
9.
Agertoft, Lone, Michael Møller, Ole Clemmensen, et al.. (2016). A child with mastocytosis and lymphomatoid papulosis. Clinical Case Reports. 4(5). 517–519. 1 indexed citations
10.
Holmström, Morten Orebo, Klaus Kallenbach, Lasse Kjær, et al.. (2015). Nye sygdomsmarkører ved de kroniske myeloproliferative neoplasier. Ugeskrift for Læger. 177(26). 2–6. 2 indexed citations
11.
Kristensen, Thomas Kielsgaard, Niels Abildgaard, Mads Thomassen, et al.. (2015). High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia. Leukemia Research. 39(6). 555–560. 16 indexed citations
12.
Kristensen, Thomas Kielsgaard, Sigurd Broesby‐Olsen, Hanne Vestergaard, Carsten Bindslev‐Jensen, & Michael Møller. (2015). Targeted ultradeep next‐generation sequencing as a method for KITD816V mutation analysis in mastocytosis. European Journal Of Haematology. 96(4). 381–388. 9 indexed citations
13.
Kristensen, Thomas Kielsgaard, Hanne Vestergaard, Carsten Bindslev‐Jensen, Michael Møller, & Sigurd Broesby‐Olsen. (2014). Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis. American Journal of Hematology. 89(5). 493–498. 83 indexed citations
14.
Altrichter, Sabine, Stefanie Becker, Thomas Kielsgaard Kristensen, et al.. (2013). Anaphylaxis caused by mosquito allergy in systemic mastocytosis. The Lancet. 382(9901). 1380–1380. 26 indexed citations
15.
Kristensen, Thomas Kielsgaard, Ole Clemmensen, & Lise Hoejberg. (2013). Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR. Journal of Molecular Diagnostics. 15(3). 355–361. 7 indexed citations
16.
Kristensen, Thomas Kielsgaard, Michael Møller, Lone Smidstrup Friis, Olav J. Bergmann, & Birgitte Preiss. (2011). NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression*. European Journal Of Haematology. 87(5). 400–408. 34 indexed citations
17.
Rathe, Mathias, Thomas Kielsgaard Kristensen, Michael Møller, & Niels Carlsen. (2010). Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate. Pediatric Blood & Cancer. 55(4). 730–732. 10 indexed citations
18.
Kristensen, Thomas Kielsgaard, et al.. (1996). [Use of fresh frozen plasma in patient treatment. Indications illustrated by a literature review and a study of practice at a university hospital].. PubMed. 158(24). 3467–70. 3 indexed citations
19.
Andersen, Lars Ib, et al.. (1996). [Rational transfusion therapy. A study of transfusion practice and possibilities of optimization in elective coronary bypass surgery].. PubMed. 158(50). 7237–40. 1 indexed citations
20.
Kristensen, Thomas Kielsgaard, et al.. (1986). A Prospective Study on the Safety of Immunotherapy in Children with Severe Asthma. Allergy. 41(8). 588–593. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026